FogPharma Stock

fogpharma.comBioTechFounded: 2016Funding to Date: $183.63MM

FogPharma is a biotechnology company developing cell-penetrating miniproteins (CPMPs) that combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for FogPharma, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Weiqing Zhou
Co-Founder & Chief Operating Officer
Howard Stern
Chief Scientific Officer
John McGee Ph.D
Executive
David Lane Ph.D
Co-Founder
Gerard Hilinski Ph.D
Co-Founder & Senior Scientist
Michael Hale Ph.D
Vice President, Chemistry
Milenko Cicmil Ph.D
Vice President, Translational Biology
Gregory Verdine Ph.D
Co-Founder, President, Chief Scientific Officer, Chief Executive Officer & Chairman

Board Members

Barbara Weber MD
Edward Fitzgerald
Gregory Verdine Ph.D
Jeffrey Leerink
SVB Leerink
Krishna Yeshwant MD
GV
Lianyong Chen Ph.D
6 Dimensions Capital
Richard Klausner MD

Other companies like FogPharma in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

/PRNewswire/ -- FogPharma today announced the appointment of Fang Wang, Ph.D., as Vice President of Biology and Nancy Wilker, Ph.D., J.D., as Vice President...